IRadimed Corp reports results for the quarter ended in December - Earnings Summary

IRADIMED

02/02/2023 14:33

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
32 cents​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for earnings of
30 cents per share.
    * Revenue rose 25.2% to $14.86 million from a year ago;
analysts
expected $14.87 million. 
    * IRadimed Corp's reported EPS for the quarter was 29
cents​.
    * The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * IRadimed Corp shares had risen by 32.4% this quarter.
    * The company reported quarterly net income of $3.67
million.
    * Wall Street's median 12-month price target for IRadimed
Corp is
$45.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
2 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.30           0.32           Beat
 Sep. 30 2022      0.25           0.29           Beat
 Jun. 30 2022      0.24           0.26           Beat
 Mar. 31 2022      0.21           0.22           Beat